- Profile
- Personal Information
- Publications
Experts in Business and Management
Gerhard J. Barone Dr. Hanumant Yadav Jack Jonck DOÄžANAY, Mehmet Mete Bernardo Balboni G. Eddy Birrer Cem Behar Bin Ke Cengiz Kallek Michael Frese Engin Akarli Andrew M. Brajcich Robert Lee Ensar Gul Irene Elisabeth De Pater RUOLIAN FANG REMUS ILIES Geraldo Cerqueiro Timothy G. Coville Ghee Soon Lim View MoreR. Lind
Chief Financial Officer
Finance
Applied Molecular Evolution
Montenegro
Mr. Kevin R. Lind has been the Chief Financial Officer and Executive Vice President at Arena Pharmaceuticals, Inc. since June 15, 2016. Mr. Lind served as the Principal Accounting Officer at Arena Pharmaceuticals, Inc. since August 10, 2016. He has with over 15 years of experience in healthcare banking and private equity. Mr. Lind is lead underwriter of TOP’s Life Sciences structured investments and drug royalty monetizations effort. Mr. Lind was the Vice President at TPG Biotech. Prior to Arena, Mr. Lind was at TPG, as a Principal at TPG Special Situations Partners and initially at TPG-Axon'sPharma Partners group. Mr. Lind was instrumental in the structured and royalty effort at TPG-Axon. Mr. Lind was a Member of the TPG Pharma Partners effort at TPG-Axon from 2006 to 2008.
Finance